510(k) Report

FDA applicant

Neotract, Inc.

Pleasanton, CA17 decisions2006–20232 recalls

FDA records 17 decisions for Neotract, Inc. (Pleasanton, CA) from 2006 to 2023: 16 510(k) clearances and 1 De Novo grant. Most are in product codes PEW (Implantable Transprostatic Tissue Retractor…) and GAT (Suture, Nonabsorbable, Synthetic, Polyethylene). Its devices cite 20 predicates, 16 of them its own earlier devices. 2 recalls are linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, gastroenterology and urology panel, where it files most

How often FDA has decided Neotract, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2023

2008: 12010: 22013: 22016: 22017: 22019: 22020: 32021: 12023: 1
2007high 3 (2020) · low 0 (2007)2026

2026 so far, outlined.

Recalls per year

1in 2022

2018: 12022: 1
2007high 1 (2018) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Neotract, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Neotract, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report